Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Other replicative DNA polymerases is a collective classification, primarily used in pharmacological databases like ChEMBL, to refer to the processive eukaryotic DNA polymerases, specifically DNA polymerase delta (Pol δ) and DNA polymerase epsilon (Pol ε). These enzymes are distinct from DNA polymerase alpha-primase, as they are responsible for the bulk of genomic DNA synthesis on the lagging and leading strands, respectively. They are characterized by high processivity, facilitated by their interaction with the Proliferating Cell Nuclear Antigen (PCNA) sliding clamp, and high fidelity due to their intrinsic 3'-5' exonuclease proofreading activity. Mutations in the catalytic subunits of these polymerases (POLE and POLD1) are linked to hypermutated and ultramutated cancer phenotypes, particularly in colorectal and endometrial cancers, making them significant biomarkers for predicting response to immune checkpoint inhibitors. Pharmacologically, these polymerases are targeted by various nucleoside analogs and antimetabolites that act as competitive inhibitors or chain terminators to disrupt DNA replication and induce apoptosis in rapidly dividing cells.
Inhibition of DNA synthesis through competitive inhibition with natural deoxynucleoside triphosphates (dNTPs) or by acting as DNA chain terminators upon incorporation into the nascent DNA strand.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other replicative DNA polymerases.